medigraphic.com
ISSN 1561-302X (Print)

2021, Number 3

<< Back Next >>

Rev cubana med 2021; 60 (3)

Subclinical atherosclerosis in health institution workers

Castro IM, Castro ID, Seoane PJM, Torres PL, González LA, Aguirre CCM

Language: Spanish
References: 29
Page: 1-12
PDF size: 409.85 Kb.


ABSTRACT

Introduction: Atherosclerosis is the main cause of coronary disease. Its presence in the vascular network is shown from very early age. It is ensured that it is present from intrauterine life and becomes larger and larger over the years, both due to the action of aging and the presence of other factors that accelerate and perpetuate it. Subclinical atherosclerosis is a term that should be used to express that there is a degree of evidence of arterial wall injury without clinical appearance.
Objective: To identify the presence of subclinical atherosclerosis and its relationship with atherogenic risk factors.
Method: A descriptive cross-sectional study was carried out in workers of “La Pradera” International Health Center from January to December 2019.
Results: Subclinical atherosclerosis was detected in 129 subjects (32.7%). It was associated with hypertension, diabetes mellitus, dyslipidemia, and smoking.
Conclusions: Subclinical disease was present in health workers, apparently healthy and young, who had at least one risk factor for atherosclerotic disease.


REFERENCES

  1. Fernández-Britto Rodríguez JE. La lesión aterosclerótica: estado del arte a las puertas del siglo xxi. Rev Cubana Invest Bioméd. 1998[acceso: 22/11/2020];17(2). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03001998000200002

  2. Statistical Review World Health Organization. 2020[acceso: 08/10/2020]. Disponible en: Disponible en: https://www.who.int

  3. Dirección de registros médicos y estadísticas de salud. Anuario Estadístico de Salud 2019. La Habana: MINSAP; 2019[acceso: 06/07/2019] p. 91-5 Disponible en: Disponible en: http://files.sld.cu/bvscuba/files/2019/04/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2018-ed-2019compressed.pdf

  4. Fuster V, Badiman L, Badiman JJ, Checebro JH. The pathogenesis of coronary artery disease and the acute coronary syndrome. (Part 1). N Engl J Med. 2000[acceso: 14/11/2020];326:242-50. Disponible en: Disponible en: https://heart.bmj.com/content/106/7/487

  5. Müller C. Xanthomata, hypercholesterolemia, angina pectoris. Acta MedScan. 1938[acceso: 14/11/2020];89(Supl 89):75-84. Disponible en: Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.0954-6820.1938.tb19279.x

  6. Loscalzo J. Regression of coronary atherosclerosis. N Engl J Med. 2001[acceso: 14/11/2020];323:1337-9. Disponible en: Disponible en: https://jamanetwork.com/journals/jama/article-abstract/384350

  7. Dawber T, Kannel W. Coronary heart disease as an epidemiology entity. Am J Public Health. 1978[acceso: 14/11/2020];53:433-7. Disponible en: Disponible en: https://ajph.aphapublications.org/doi/pdf/10.2105/AJPH.53.3.433

  8. Bilheimer D. Therapeutic control of hyperlipidemia in the prevention of Coronary atherosclerosis: A review of results from recent clinical trials. Am J Card. 1988[acceso: 14/11/2020];11(62):1J-9J. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/abs/pii/000291498890001X

  9. Nissen SE, Gurley JC, Grines CL, Booth DC, McClure R, Berk M, et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation. 1991;84(3):1087-99. Disponible en: https://doi.org/10.1161/01.cir.84.3.1087.PMID: 1884441

  10. Water D, Lespérance J. Regression of coronary atherosclerosis: an achievable goal? Review of results from recent clinical trials. Am J Med. 1991[acceso: 14/10/2020];91(1 Suppl 2):10S-17S. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/abs/pii/000293439190051X

  11. Brensike J, Levy R, Kelsey S, Passamani E, Richardson J, Loh I, et al. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI type II coronary intervention study. Circulation. 1984[acceso: 14/11/2020];69:313-24. Disponible en: Disponible en: https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.69.2.313

  12. Branch LB. The lipid research clinics coronary primary prevention trial results. Reduction in incidence of coronary heart disease. JAMA. 1984;251(3):351-64. https://doi.org/ 10.1001/jama.1984.03340270029025

  13. Griessenauer CHJ, Farrell S, Sarkar A, ZandR Abedi V, Holland N, Michael A, et al. Genetic susceptibility to cerebrovascular disease: A systematic review. J Cereb Blood Flow Metab. 2018[acceso: 14/11/2020];38(11):1853-71. Disponible en: Disponible en: https://journals.sagepub.com/doi/pdf/10.1177/0271678X18797958

  14. Moreyra E, Lorenzatti D, Moreyra C, Arias V, Tibaldi MA, Lepori AJ, et al. Comparison of risk scores to predict subclinical atherosclerosis. Medicina (B Aires). 2019[acceso: 14/11/2020];79(5):373-83. Disponible en: Disponible en: https://europepmc.org/article/med/31671387

  15. Baber U, Mehran R, Sartori S. Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: The BioImage Study. J Am Coll Cardiol. 2015[acceso: 14/11/2020];65:1065-74. Disponible en: Disponible en: https://www.jacc.org/doi/pdf/10.1016/j.jacc.2015.01.017

  16. Mitu O, Roca M, Floria M, Petris AO, Graur M, Mitu, et al. Subclinical cardiovascular disease assessment and its relationship with cardiovascular risk SCORE in a healthy adult population: A cross-sectional community-based study. Clin Inv Art. 2017[acceso: 14/11/2020];29(3):111-19. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28377040/

  17. Zhang P, Li D, Su Y, Wang X, Sun J, Xu Y, et al. Assessment of myocardial strain in children with risk factors for atherosclerosis with use of 3D speckle tracking echocardiography. Echocardiography. 2018[acceso: 14/11/2020];35(4):487-93. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/29399870/

  18. Fernström M, Fernberg U, Eliason G, Hurtig-Wennlöf A. Aerobic fitness is associated with low cardiovascular disease risk: the impact of lifestyle on early risk factors for atherosclerosis in young healthy Swedish individuals -the Lifestyle, Biomarker, and Atherosclerosis study. Vasc Health Risk Manag. 2017[acceso: 14/11/2020];13:91-99. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28352184/

  19. López-Melgar B, Fernández-Friera L, Oliva B, García-Ruiz JM, Peñalvo JL, Gómez-Talavera S, et al. Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study. J Am Coll Cardiol. 2017 [acceso: 25/10/2020];70(3):301-13. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28705310/

  20. Rodríguez-Perón JM. Cuantificación imagenológica no invasiva de la carga aterosclerótica en la evaluación avanzada del riesgo cardiovascular. Rev. Cuban. Med. Mil. 2020[acceso: 12/12/2020];49(4):0200530. Disponible en: Disponible en: http://revmedmilitar.sld.cu/index.php/mil/article/view/530/639

  21. Çetin M, Erdoğan T, Kırış T, Özyıldız AG, Ergül E, Durakoğlugil E, et al. Endothelial dysfunction, subclinical atherosclerosis and LDL cholesterol are the independent predictors of left atrial functions in hypertension. Int J Cardiovasc Imaging. 2020[acceso: 25/10/2020];36(1):69-77. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31586295/

  22. Spannella F, Di Pentima C, Giulietti F, Buscarini S, Ristori L, Giordano P, et al. Prevalence of subclinical carotid atherosclerosis and role of cardiovascular risk factors in older adults: atherosclerosis and aging are not synonyms. High Blood Press Cardiovasc Prev. 2020[acceso: 14/11/2020];27(3):231-38. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32219668/

  23. Torres-Damas EL. Factores de riesgos aterogénico y su relación con la lesión carotidea identificada por eco-doppler. Rev. Cub. Angiol. Cir Vasc. 2018[acceso: 23/07/2020];19(2):119-32. Disponible en: Disponible en: http://scielo.sld.cu/pdf/ang/v19n2/ang06218.pdf

  24. Al Rifai M, Martin SS, McEvoy JW, Nasir K, Blankstein R, Yeboah J, et al. The prevalence and correlates of subclinical atherosclerosis among adults with lowdensity lipoprotein cholesterol < 70 mg/dL: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSABrasil). Atherosclerosis. 2018[acceso: 14/11/2020];274:61-66. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/29751286/

  25. Toth PP, Patti AM, Nikolic D, Giglio RV, Castellino G, Biancucci T, et al. Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 month’s prospective study. Pharmacol. 2016[acceso: 14/11/2020];6:299. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/26779019/

  26. Herrera González A, González Díaz D, Tamargo Barbeito T, Soto Margo J, Peña Garcell Y. Factores pronósticos de aterosclerosis subclínica en pacientes dislipidémicos. Rev Cubana Med. 2020[acceso: 08/10/2020];59(4):e1663. Disponible en: Disponible en: http://revmedicina.sld.cu/index.php/med/article/view/1663

  27. Tribin Rivero K, Oro Montero LP, Hernández Ramírez I. Papel de los lípidos y las lipoproteínas en la aterosclerosis. Correo Científico Médico (CCM). 2020[acceso: 08/10/20];24(2). Disponible en: Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/3518

  28. Penagos-Noriega S, Guerrero-Avendaño GM, Solís-Rodríguez R. Caracterización de la ateromatosis carotídea con ultrasonido Doppler. Anales de Radiología México. 2016[acceso: 07/09/2020];15(4):308-16. Disponible en Disponible en https://www.medigraphic.com/pdfs/anaradmex/arm-2016/arm164g.pdf

  29. Luirink IK, Kuipers IM, Hutten BA, Planken RN, Backx APCM, Groothoff JW, et al. Coronary computed tomography angiography and echocardiography in children with homozygous familial hypercholesterolemia. Atherosclerosis. 2019[acceso: 14/11/2020];285:87-92. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31048103/




2020     |     www.medigraphic.com